Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01727713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette's Disorder
Tic Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.